These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25201169)

  • 21. Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study.
    Suehs CM; Menzies-Gow A; Price D; Bleecker ER; Canonica GW; Gurnell M; Bourdin A;
    Am J Respir Crit Care Med; 2021 Apr; 203(7):871-881. PubMed ID: 33112646
    [No Abstract]   [Full Text] [Related]  

  • 22. Extrapulmonary associations of health status in severe asthma and bronchiectasis: Comorbidities and functional outcomes.
    Cordova-Rivera L; Gibson PG; Gardiner PA; Hiles SA; McDonald VM
    Respir Med; 2019; 154():93-101. PubMed ID: 31229944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand.
    Blakey J; Chung LP; McDonald VM; Ruane L; Gornall J; Barton C; Bosnic-Anticevich S; Harrington J; Hew M; Holland AE; Hopkins T; Jayaram L; Reddel H; Upham JW; Gibson PG; Bardin P
    Respirology; 2021 Dec; 26(12):1112-1130. PubMed ID: 34587348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life burden in severe asthma.
    McDonald VM; Hiles SA; Jones KA; Clark VL; Yorke J
    Med J Aust; 2018 Jul; 209(S2):S28-S33. PubMed ID: 30453870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life, anxiety, depression, beliefs of medication, and self-efficacy in individuals with severe asthma - a population-based study.
    Rönnebjerg L; Axelsson M; Kankaanranta H; Ekerljung L
    J Asthma; 2024 Feb; 61(2):148-159. PubMed ID: 37610189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of an OCS-dependent severe asthma population treated with mepolizumab.
    Prazma CM; Wenzel S; Barnes N; Douglass JA; Hartley BF; Ortega H
    Thorax; 2014 Dec; 69(12):1141-2. PubMed ID: 24834924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing Corticosteroid-Related Comorbidities in Severe Asthma.
    Sood V; Rogers L; Khurana S
    Chest; 2021 Nov; 160(5):1614-1623. PubMed ID: 34019864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use.
    Zazzali JL; Broder MS; Omachi TA; Chang E; Sun GH; Raimundo K
    Allergy Asthma Proc; 2015; 36(4):268-74. PubMed ID: 26108084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.
    Chupp GL; Bradford ES; Albers FC; Bratton DJ; Wang-Jairaj J; Nelsen LM; Trevor JL; Magnan A; Ten Brinke A
    Lancet Respir Med; 2017 May; 5(5):390-400. PubMed ID: 28395936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
    J Allergy Clin Immunol Pract; 2017; 5(4):1050-1060.e9. PubMed ID: 28215604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
    Heaney LG; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker SM; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Mansur AH; Fowler SJ; Niven RM; Howarth PH; Lordan JL; Menzies-Gow A; Harrison TW; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID;
    Lancet Respir Med; 2021 Jan; 9(1):57-68. PubMed ID: 32916135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asthma-like symptoms in the first year of life and health-related quality of life at age 12 months: the Generation R study.
    Mohangoo AD; de Koning HJ; de Jongste JC; Landgraf JM; van der Wouden JC; Jaddoe VW; Hofman A; Moll HA; Mackenbach JP; Raat H
    Qual Life Res; 2012 Apr; 21(3):545-54. PubMed ID: 21792733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia.
    Schölzel-Dorenbos CJ; Arons AM; Wammes JJ; Rikkert MG; Krabbe PF
    Health Qual Life Outcomes; 2012 Sep; 10():118. PubMed ID: 23009579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in oral corticosteroids use in severe asthma: a 14-year population-based study.
    Sadatsafavi M; Khakban A; Tavakoli H; Ehteshami-Afshar S; Lynd LD; FitzGerald JM
    Respir Res; 2021 Apr; 22(1):103. PubMed ID: 33836765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of omalizumab in severe allergic asthma: a retrospective UK real-world study.
    Barnes N; Menzies-Gow A; Mansur AH; Spencer D; Percival F; Radwan A; Niven R
    J Asthma; 2013 Jun; 50(5):529-36. PubMed ID: 23574000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
    Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of short-term oral corticosteroid intake on dietary intake, body weight and body composition in adults with asthma - a randomized controlled trial.
    Berthon BS; Gibson PG; McElduff P; MacDonald-Wicks LK; Wood LG
    Clin Exp Allergy; 2015 May; 45(5):908-919. PubMed ID: 25640664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "I have lost in every facet of my life": the hidden burden of severe asthma.
    Foster JM; McDonald VM; Guo M; Reddel HK
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28931662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study).
    Niven RM; Saralaya D; Chaudhuri R; Masoli M; Clifton I; Mansur AH; Hacking V; McLain-Smith S; Menzies-Gow A
    BMJ Open; 2016 Aug; 6(8):e011857. PubMed ID: 27507234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis.
    Prazma CM; Bel EH; Price RG; Bradford ES; Albers FC; Yancey SW
    Respir Res; 2019 May; 20(1):83. PubMed ID: 31053134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.